Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hailin Tang

Showing results (91-100 of 341) with videos related to

Pageof 35
Sort By:
Molecular Therapy. Nucleic Acids|September 20, 2019
circFBXW7 Inhibits Malignant Progression by Sponging miR-197-3p and Encoding a 185-aa Protein in Triple-Negative Breast CancerFeng Ye, Guanfeng Gao, Yutian Zou, et al.
Frontiers in Oncology|January 1, 2026
Editorial: The insights of multi-omics into the microenvironment after tumor metastasis: a paradigm shift in molecular targeting modeling and immunotherapy for advanced cancer patientsXuejian Liu, Qi Wang, Yang Ma, et al.
Cancer Letters|April 7, 2025
RNA methyltransferase METTL16: From molecular mechanisms to therapeutic prospects in cancersZhaohu Shi, Xiankui Cao, Yiming Ma, et al.
Frontiers in Bioscience (Landmark Edition)|March 28, 2025
An MRI Radiogenomic Signature to Characterize the Transcriptional Heterogeneity Associated with Prognosis and Biological Functions in GlioblastomaXiaoqing Zhang, Xiaoyu Zhang, Jie Zhu, et al.
Imetaomics|February 12, 2026
A glimpse into the future: Integrating artificial intelligence for precision HER2-positive breast cancer managementXinpei Deng, Yixuan Yan, Zekai Zhan, et al.
Frontiers in Immunology|January 30, 2026
The role of immune checkpoint molecules in cancersMeilan Zhang, Junjie Xu, Zhaokuan Zheng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 22, 2017
Linc00152 promotes tumorigenesis by regulating DNMTs in triple-negative breast cancerJiali Wu, Zeyu Shuang, Jianfu Zhao, et al.
Plos One|November 17, 2016
Pretreatment Hematocrit Is Superior to Hemoglobin as a Prognostic Factor for Triple Negative Breast CancerBo Chen, Danian Dai, Hailin Tang, et al.
Phytotherapy Research : PTR|April 25, 2015
A Review: The Pharmacology of IsoliquiritigeninFu Peng, Qiaohui Du, Cheng Peng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 20, 2020
Corrigendum to "Linc00152 promotes tumorigenesis by regulating DNMTs in triple-negative breast cancer" [Biomed Pharmacother. 97 (2018) 1275-1281]Jiali Wu, Zeyu Shuang, Jianfu Zhao, et al.
Pageof 35

Showing results (91-100 of 341) with videos related to

Sort By:
Pageof 35
Molecular Therapy. Nucleic Acids|September 20, 2019
circFBXW7 Inhibits Malignant Progression by Sponging miR-197-3p and Encoding a 185-aa Protein in Triple-Negative Breast CancerFeng Ye, Guanfeng Gao, Yutian Zou, et al.
Frontiers in Oncology|January 1, 2026
Editorial: The insights of multi-omics into the microenvironment after tumor metastasis: a paradigm shift in molecular targeting modeling and immunotherapy for advanced cancer patientsXuejian Liu, Qi Wang, Yang Ma, et al.
Cancer Letters|April 7, 2025
RNA methyltransferase METTL16: From molecular mechanisms to therapeutic prospects in cancersZhaohu Shi, Xiankui Cao, Yiming Ma, et al.
Frontiers in Bioscience (Landmark Edition)|March 28, 2025
An MRI Radiogenomic Signature to Characterize the Transcriptional Heterogeneity Associated with Prognosis and Biological Functions in GlioblastomaXiaoqing Zhang, Xiaoyu Zhang, Jie Zhu, et al.
Imetaomics|February 12, 2026
A glimpse into the future: Integrating artificial intelligence for precision HER2-positive breast cancer managementXinpei Deng, Yixuan Yan, Zekai Zhan, et al.
Frontiers in Immunology|January 30, 2026
The role of immune checkpoint molecules in cancersMeilan Zhang, Junjie Xu, Zhaokuan Zheng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 22, 2017
Linc00152 promotes tumorigenesis by regulating DNMTs in triple-negative breast cancerJiali Wu, Zeyu Shuang, Jianfu Zhao, et al.
Plos One|November 17, 2016
Pretreatment Hematocrit Is Superior to Hemoglobin as a Prognostic Factor for Triple Negative Breast CancerBo Chen, Danian Dai, Hailin Tang, et al.
Phytotherapy Research : PTR|April 25, 2015
A Review: The Pharmacology of IsoliquiritigeninFu Peng, Qiaohui Du, Cheng Peng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 20, 2020
Corrigendum to "Linc00152 promotes tumorigenesis by regulating DNMTs in triple-negative breast cancer" [Biomed Pharmacother. 97 (2018) 1275-1281]Jiali Wu, Zeyu Shuang, Jianfu Zhao, et al.
Pageof 35